NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
关于老挝专利「NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)」，老商通整理了如下公开信息，由 AiCuris GmbH & Co. KG 于 2019-11-01 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/772，DIP 编号 LAP772，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-04-03。技术或外观分类记载为 A61K 31/4985、A61P 31/12、C07D 487/04。发明人 / 设计人包括 BONSMANN, Susanne、DONALD, Alastair、SPRINGER, Jasper、URBAN, Andreas、WEGERT, Anita。代理机构 / 代理人记载为 LAO TRADEMARK AGENCY (LAO IP AGENCY)。公开摘要提示：The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…。
LaoBiz profiles the Laos patent “NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)” from open registry fields, filed by AiCuris GmbH & Co. KG on 2019-11-01; current status: Awaiting formal examination. Identifiers include application No. P/772; DIP id LAP772; protection kind Patent - PCT National Phase. Key dates: publication 2026-04-03. Classification: A61K 31/4985、A61P 31/12、C07D 487/04. Inventor(s)/designer(s): BONSMANN, Susanne, DONALD, Alastair, SPRINGER, Jasper, URBAN, Andreas, WEGERT, Anita. Abstract hint: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…. Use LaoBiz to hop between this IP record, related filings by the same applicant, and the matched company profile when present.
ກ່ຽວກັບ ສິດທິບັດ «NOVEL 6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)» ໃນລາວ, ຍື່ນໂດຍ AiCuris GmbH & Co. KG ໃນວັນທີ 2019-11-01; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/772; ລະຫັດ DIP LAP772; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-04-03. ປະເພດ/ຫ້ອງ: A61K 31/4985、A61P 31/12、C07D 487/04. ນັກປະດິດ/ນັກອອກແບບ: BONSMANN, Susanne, DONALD, Alastair, SPRINGER, Jasper, URBAN, Andreas, WEGERT, Anita. ສະຫຼຸບ: ການປະດິດສ້າງໃນປະຈຸບັນກ່ຽວຂ້ອງກັບໂດຍທົ່ວໄປແລ້ວກັບຕົວແທນຕ້ານເຊື້ອໄວຣັສໃໝ່. ໂດຍສະເພາະ, ການປະດິດປະຈຸບັນກ່ຽວຂ້ອງກັບສານປະກອບທີ່ສາມາດຢັບຢັ້ງທາດໂປຼ…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/772
图样
基础信息
- 类型
- 专利
- 申请号
P/772- 状态
- 等待形式审查
- 申请人
- AiCuris GmbH & Co. KG
- 代理机构
- LAO TRADEMARK AGENCY (LAO IP AGENCY)
- 申请日期
- 2019-11-01
- 公开/公告日
- 2026-04-03
- 国际分类
- A61K 31/4985 · A61P 31/12 · C07D 487/04
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
ການປະດິດສ້າງໃນປະຈຸບັນກ່ຽວຂ້ອງກັບໂດຍທົ່ວໄປແລ້ວກັບຕົວແທນຕ້ານເຊື້ອໄວຣັສໃໝ່. ໂດຍສະເພາະ, ການປະດິດປະຈຸບັນກ່ຽວຂ້ອງກັບສານປະກອບທີ່ສາມາດຢັບຢັ້ງທາດໂປຼຕີນທີ່ເຂົ້າລະຫັດໂດຍເຊື້ອໄວຣັດຕັບອັກເສບ B (HBV) ຫຼືແຊກແຊງການເຮັດວຽກຂອງວົງຈອນການຈໍາລອງ HBV, ອົງປະກອບທີ່ປະກອບດ້ວຍທາດປະສົມດັ່ງກ່າວ, ວິທີການສະກັດກັ້ນການຈໍາລອງເຊື້ອໄວຣັສ HBV, ວິທີການປິ່ນປົວ. ຫຼື ປ້ອງກັນການຕິດເຊື້ອ HBV, ແລະ ຂະບວນການ ແລະ ຕົວກາງສໍາລັບການເຮັດທາດປະສົມ.
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.